THE STRATEGIC RESEARCH AGENDA
Through extensive consultation with national funding agencies, industry and international stakeholders, JPIAMR has developed a Strategic Research Agenda (SRA) which outlines six priority topics that cover all relevant aspects of antimicrobial resistance.
A
THERAPEUTICS
The improvement of current antibiotics and treatment regimens, the development of new antibiotics and therapeutic alternatives to antibiotics.
B
DIAGNOSTICS
The improvement of diagnostics and the development of novel (rapid) diagnostics to stimulate better use of current antibiotics and support the development and use of new antibiotics and alternatives to antibiotics.
C
SURVEILLANCE
The establishment of an international, standardised surveillance programme for AMR and antibiotic use in human, and agricultural settings.
D
TRANSMISSION
A comprehensive, multi-disciplinary understanding of the transmission mechanisms by which antibiotic resistance can spread between bacterial populations and between different (animal and human) reservoir and to translate this knowledge into the development of evidence-based strategies to minimize the spread of resistance.
E
ENVIRONMENT
The assessment of the contribution of pollution of the environment with antibiotics, antibiotic residues and resistant bacteria on the spread of AMR and the development of strategies to minimize environmental contamination by antibiotics and resistant bacteria.
F
INTERVENTIONS
The study of preventive and control interventions that focus on improved antibiotic stewardship, compliance and prevention of transmission of AMR and to determine and improve their efficacy.
